Volume 70, Issue 5, Pages (November 2016)

Slides:

Advertisements

Similar presentations

Volume 56, Issue 5, Pages (November 2009)

Advertisements

Volume 70, Issue 3, Pages (September 2016)

The PSA Era is not Over for Prostate Cancer

Volume 57, Issue 1, Pages (January 2010)

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 57, Issue 5, Pages (May 2010)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 53, Issue 4, Pages (April 2008)

Volume 70, Issue 6, Pages (December 2016)

Volume 60, Issue 5, Pages (November 2011)

Volume 70, Issue 1, Pages (July 2016)

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 50, Issue 5, Pages (November 2006)

Volume 69, Issue 1, Pages (January 2016)

Volume 51, Issue 4, Pages (April 2007)

Volume 70, Issue 4, Pages (October 2016)

Volume 51, Issue 5, Pages (May 2007)

Prostate Cancer Epidemic in Sight?

Volume 64, Issue 4, Pages (October 2013)

John P. Mulhall, Francesco Montorsi European Urology

Daily Administration of Phosphodiesterase Type 5 Inhibitors for Urological and Nonurological Indications Anthony J. Bella, Ling X. DeYoung, Mussa al-Numi,

Volume 64, Issue 4, Pages (October 2013)

Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer Sam Ladjevardi, Gabriel Sandblom,

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 73, Issue 3, Pages (March 2018)

Volume 54, Issue 4, Pages (October 2008)

Volume 74, Issue 4, Pages (October 2018)

Elizabeth K. Bancroft, Rosalind A. Eeles

Volume 63, Issue 6, Pages (June 2013)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 70, Issue 5, Pages (November 2016)

Volume 69, Issue 3, Pages (March 2016)

Shaheen Alanee, Kasmintan Schrader, Kenneth Offit European Urology

Volume 71, Issue 6, Pages (June 2017)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Yuanshan Cui, Yong Zhang European Urology

Volume 71, Issue 4, Pages (April 2017)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 4, Pages (October 2010)

Volume 53, Issue 4, Pages (April 2008)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 65, Issue 6, Pages (June 2014)

Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 50, Issue 5, Pages (November 2006)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Testicular Cancer Variations in Time and Space in Europe

Volume 59, Issue 4, Pages (April 2011)

Volume 70, Issue 1, Pages (July 2016)

Volume 75, Issue 3, Pages (March 2019)

Volume 71, Issue 3, Pages (March 2017)

European Urology is “Your” Journal

Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Vaccinations against respiratory tract infections at Hajj

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation

Presentation transcript:

Volume 70, Issue 5, Pages 808-815 (November 2016) Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer Yi Lian, Hui Yin, Michael N. Pollak, Serge Carrier, Robert W. Platt, Samy Suissa, Laurent Azoulay European Urology Volume 70, Issue 5, Pages 808-815 (November 2016) DOI: 10.1016/j.eururo.2016.04.035 Copyright © 2016 Terms and Conditions

Fig. 1 Study flow diagram describing the assembly of the erectile dysfunction cohort using the UK Clinical Practice Research Datalink. ED=erectile dysfunction; PDE5-I=phosphodiesterase type 5 inhibitor. European Urology 2016 70, 808-815DOI: (10.1016/j.eururo.2016.04.035) Copyright © 2016 Terms and Conditions

Fig. 2 Forest plots summarizing the sensitivity analyses for melanoma skin cancer. CI=confidence interval; HR=hazard ratio. * Cohort restricted to patients with at least one health-seeking behavior (influenza vaccination, referral to colonoscopy and prostate-specific antigen testing) in the year before cohort entry. European Urology 2016 70, 808-815DOI: (10.1016/j.eururo.2016.04.035) Copyright © 2016 Terms and Conditions